By using a high resolution top-down and bottom-up approach we identified and characterized the AGEs of beta2-microglobulin (β2-m) formed by incubating the protein in the presence of glucose and of the main reactive carbonyl species. Glucose induced glycation on the N-terminal residue, while glyoxal (GO) and methylglyoxal (MGO) covalently reacted with Arg3. Carboxymethyl (CM-R) and imidazolinone (R-GO) derivatives were identified in the case of GO and carboxyethyl arginine (CE-R) and methyl-imidazolinone (R-MGO) for MGO. Interestingly, α,β-unsaturated aldehydes [4-hydroxy-2-nonenal (HNE); 4-oxo-2-nonenal (ONE); acrolein (ACR)] did not induce any covalent modifications up to 100μM. The different reactivity of β2-m towards the different RCS was then rationalized by molecular modeling studies. The MS method was then applied to fully characterize the AGEs of β2-m isolated from the urine of uremic subjects. CM-R, CE-R and R-MGO were easily identified on Arg3 and their relative abundance in respect to the native protein determined by a semi-quantitative approach. Overall, the AGEs content of urinary β2-m ranged from 0.2 to 1% in uremic subjects. The results here reported offer novel insights and technical achievements for a potential biological role of AGEs-β2-m in pathological conditions. © 2013 Elsevier B.V.

Advanced glycation end products of beta2-microglobulin in uremic patients as determined by high resolution mass spectrometry / L. Bertoletti, L. Regazzoni, A. Altomare, R. Colombo, M. Colzani, G. Vistoli, L. Marchese, M. Carini, E. De Lorenzi, G. Aldini. - In: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. - ISSN 0731-7085. - 91(2014 Mar), pp. 193-201. [10.1016/j.jpba.2013.12.021]

Advanced glycation end products of beta2-microglobulin in uremic patients as determined by high resolution mass spectrometry

L. Regazzoni
Secondo
;
A. Altomare;R. Colombo;M. Colzani;G. Vistoli;M. Carini;G. Aldini
Ultimo
2014

Abstract

By using a high resolution top-down and bottom-up approach we identified and characterized the AGEs of beta2-microglobulin (β2-m) formed by incubating the protein in the presence of glucose and of the main reactive carbonyl species. Glucose induced glycation on the N-terminal residue, while glyoxal (GO) and methylglyoxal (MGO) covalently reacted with Arg3. Carboxymethyl (CM-R) and imidazolinone (R-GO) derivatives were identified in the case of GO and carboxyethyl arginine (CE-R) and methyl-imidazolinone (R-MGO) for MGO. Interestingly, α,β-unsaturated aldehydes [4-hydroxy-2-nonenal (HNE); 4-oxo-2-nonenal (ONE); acrolein (ACR)] did not induce any covalent modifications up to 100μM. The different reactivity of β2-m towards the different RCS was then rationalized by molecular modeling studies. The MS method was then applied to fully characterize the AGEs of β2-m isolated from the urine of uremic subjects. CM-R, CE-R and R-MGO were easily identified on Arg3 and their relative abundance in respect to the native protein determined by a semi-quantitative approach. Overall, the AGEs content of urinary β2-m ranged from 0.2 to 1% in uremic subjects. The results here reported offer novel insights and technical achievements for a potential biological role of AGEs-β2-m in pathological conditions. © 2013 Elsevier B.V.
No
English
Advanced glycoxidation end products ; Beta2-microglobulin ; Dialysis related amyloidosis ; Mass spectrometry ; Oxidative stress ; Reactive carbonyl species
Settore CHIM/08 - Chimica Farmaceutica
Articolo
Esperti anonimi
Ricerca di base
Pubblicazione scientifica
mar-2014
Elsevier
91
193
201
9
Pubblicato
Periodico con rilevanza internazionale
Aderisco
info:eu-repo/semantics/article
Advanced glycation end products of beta2-microglobulin in uremic patients as determined by high resolution mass spectrometry / L. Bertoletti, L. Regazzoni, A. Altomare, R. Colombo, M. Colzani, G. Vistoli, L. Marchese, M. Carini, E. De Lorenzi, G. Aldini. - In: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. - ISSN 0731-7085. - 91(2014 Mar), pp. 193-201. [10.1016/j.jpba.2013.12.021]
reserved
Prodotti della ricerca::01 - Articolo su periodico
10
262
Article (author)
no
L. Bertoletti, L. Regazzoni, A. Altomare, R. Colombo, M. Colzani, G. Vistoli, L. Marchese, M. Carini, E. De Lorenzi, G. Aldini
File in questo prodotto:
File Dimensione Formato  
JPBA_2014_UREMIC PATIENTS.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 727.56 kB
Formato Adobe PDF
727.56 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/236092
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact